Cargando…

The diagnostic value of modified systemic ınflammation score in predicting post-operative outcomes of cutaneous melanoma patients who underwent ısolated limb perfusion

BACKGROUND: In-transit metastasis is considered a locoregional disease in cutaneous melanoma (CM) patients. Isolated limb perfusion (ILP) is among the treatment options in selected cases. The aim of this study was to determine the success of pre- and post-perfusion mSIS values in predicting the pote...

Descripción completa

Detalles Bibliográficos
Autores principales: Morkavuk, Şevket Barış, Çulcu, Serdar, Esen, Ebru, Ünal, Ali Ekrem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594072/
https://www.ncbi.nlm.nih.gov/pubmed/34781987
http://dx.doi.org/10.1186/s12957-021-02437-6
_version_ 1784599891568230400
author Morkavuk, Şevket Barış
Çulcu, Serdar
Esen, Ebru
Ünal, Ali Ekrem
author_facet Morkavuk, Şevket Barış
Çulcu, Serdar
Esen, Ebru
Ünal, Ali Ekrem
author_sort Morkavuk, Şevket Barış
collection PubMed
description BACKGROUND: In-transit metastasis is considered a locoregional disease in cutaneous melanoma (CM) patients. Isolated limb perfusion (ILP) is among the treatment options in selected cases. The aim of this study was to determine the success of pre- and post-perfusion mSIS values in predicting the potential complications and the prognosis of the disease by investigating the early and long-term results of mSIS values calculated before and after ILP in CM cases with in-transit metastases. MATERIALS AND METHODS: Patients who underwent ILP within the period from 2014 to 2020 in our department were retrospectively scanned. A total of 20 patients were found to undergo ILP. The scores obtained from modified inflammation score (mSIS) were formulated according to albumin (Alb) and lymphocyte to monocyte ratio (LMR) scores. RESULTS: The mean follow-up time was 20.47 months. Complications requiring surgical intervention developed in three patients. According to the Wieberdink local toxicity classification, the majority (70%) of the patients were found to be grade II. Based on pre-perfusion mSIS values, 8 patients were classified as mSIS 0 while six patients were classified as mSIS 1 and 2. Based on post-perfusion mSIS values, 14 patients and one patient were classified as mSIS 2 (70%) and mSIS 0, respectively. Accordingly, univariate analysis showed that mSIS 1 and mSIS 2 were negative prognostic factors for mean survival in the pre-perfusion period (HR 0.162, 95% CI 0.036–0.729; p = 0.018 and HR: 0.223, 95% CI 0.049–1.019; p = 0.053) whereas albumin (Alb) and lymphocyte to monocyte ratio (LMR) were not independent prognostic factors for mean survival. CONCLUSION: The mSIS values calculated in the pre-perfusion period can give an opinion about the OS of the patients whereas post-perfusion mSIS values may predict potential surgical complications and local toxicities.
format Online
Article
Text
id pubmed-8594072
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85940722021-11-16 The diagnostic value of modified systemic ınflammation score in predicting post-operative outcomes of cutaneous melanoma patients who underwent ısolated limb perfusion Morkavuk, Şevket Barış Çulcu, Serdar Esen, Ebru Ünal, Ali Ekrem World J Surg Oncol Research BACKGROUND: In-transit metastasis is considered a locoregional disease in cutaneous melanoma (CM) patients. Isolated limb perfusion (ILP) is among the treatment options in selected cases. The aim of this study was to determine the success of pre- and post-perfusion mSIS values in predicting the potential complications and the prognosis of the disease by investigating the early and long-term results of mSIS values calculated before and after ILP in CM cases with in-transit metastases. MATERIALS AND METHODS: Patients who underwent ILP within the period from 2014 to 2020 in our department were retrospectively scanned. A total of 20 patients were found to undergo ILP. The scores obtained from modified inflammation score (mSIS) were formulated according to albumin (Alb) and lymphocyte to monocyte ratio (LMR) scores. RESULTS: The mean follow-up time was 20.47 months. Complications requiring surgical intervention developed in three patients. According to the Wieberdink local toxicity classification, the majority (70%) of the patients were found to be grade II. Based on pre-perfusion mSIS values, 8 patients were classified as mSIS 0 while six patients were classified as mSIS 1 and 2. Based on post-perfusion mSIS values, 14 patients and one patient were classified as mSIS 2 (70%) and mSIS 0, respectively. Accordingly, univariate analysis showed that mSIS 1 and mSIS 2 were negative prognostic factors for mean survival in the pre-perfusion period (HR 0.162, 95% CI 0.036–0.729; p = 0.018 and HR: 0.223, 95% CI 0.049–1.019; p = 0.053) whereas albumin (Alb) and lymphocyte to monocyte ratio (LMR) were not independent prognostic factors for mean survival. CONCLUSION: The mSIS values calculated in the pre-perfusion period can give an opinion about the OS of the patients whereas post-perfusion mSIS values may predict potential surgical complications and local toxicities. BioMed Central 2021-11-16 /pmc/articles/PMC8594072/ /pubmed/34781987 http://dx.doi.org/10.1186/s12957-021-02437-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Morkavuk, Şevket Barış
Çulcu, Serdar
Esen, Ebru
Ünal, Ali Ekrem
The diagnostic value of modified systemic ınflammation score in predicting post-operative outcomes of cutaneous melanoma patients who underwent ısolated limb perfusion
title The diagnostic value of modified systemic ınflammation score in predicting post-operative outcomes of cutaneous melanoma patients who underwent ısolated limb perfusion
title_full The diagnostic value of modified systemic ınflammation score in predicting post-operative outcomes of cutaneous melanoma patients who underwent ısolated limb perfusion
title_fullStr The diagnostic value of modified systemic ınflammation score in predicting post-operative outcomes of cutaneous melanoma patients who underwent ısolated limb perfusion
title_full_unstemmed The diagnostic value of modified systemic ınflammation score in predicting post-operative outcomes of cutaneous melanoma patients who underwent ısolated limb perfusion
title_short The diagnostic value of modified systemic ınflammation score in predicting post-operative outcomes of cutaneous melanoma patients who underwent ısolated limb perfusion
title_sort diagnostic value of modified systemic ınflammation score in predicting post-operative outcomes of cutaneous melanoma patients who underwent ısolated limb perfusion
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594072/
https://www.ncbi.nlm.nih.gov/pubmed/34781987
http://dx.doi.org/10.1186/s12957-021-02437-6
work_keys_str_mv AT morkavuksevketbarıs thediagnosticvalueofmodifiedsystemicınflammationscoreinpredictingpostoperativeoutcomesofcutaneousmelanomapatientswhounderwentısolatedlimbperfusion
AT culcuserdar thediagnosticvalueofmodifiedsystemicınflammationscoreinpredictingpostoperativeoutcomesofcutaneousmelanomapatientswhounderwentısolatedlimbperfusion
AT esenebru thediagnosticvalueofmodifiedsystemicınflammationscoreinpredictingpostoperativeoutcomesofcutaneousmelanomapatientswhounderwentısolatedlimbperfusion
AT unalaliekrem thediagnosticvalueofmodifiedsystemicınflammationscoreinpredictingpostoperativeoutcomesofcutaneousmelanomapatientswhounderwentısolatedlimbperfusion
AT morkavuksevketbarıs diagnosticvalueofmodifiedsystemicınflammationscoreinpredictingpostoperativeoutcomesofcutaneousmelanomapatientswhounderwentısolatedlimbperfusion
AT culcuserdar diagnosticvalueofmodifiedsystemicınflammationscoreinpredictingpostoperativeoutcomesofcutaneousmelanomapatientswhounderwentısolatedlimbperfusion
AT esenebru diagnosticvalueofmodifiedsystemicınflammationscoreinpredictingpostoperativeoutcomesofcutaneousmelanomapatientswhounderwentısolatedlimbperfusion
AT unalaliekrem diagnosticvalueofmodifiedsystemicınflammationscoreinpredictingpostoperativeoutcomesofcutaneousmelanomapatientswhounderwentısolatedlimbperfusion